Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Ipamorelin: The Peptide Perspective Ipamorelin SummaryIpamorelin Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), which displays high GH-releasing potency and efficacy in vitro and in vivo.Ipamorelin, a selective growth hormone-releasing peptide, has emerged as a promising agent for female fat loss
single-agonist frameworks Metabolic dysfunction models including insulin resistance pathways Islet biology and receptor-specific insulin/glucagon secretion studies Product Specifications Peptide Length: 39 amino acids Receptor Targets: GLP-1R and GIPR Agonist Profile: Balanced dual-incretin activation (GLP-1R + GIPR) Form: Lyophilized powder for laboratory research Purity: 99% (HPLC verified, COA available) Storage: Store at -20C, protected from light and moisture
268271 (IEEE)
By 2017 revenue from liraglutide was US $843 million, and the overall market for GLP-1 drugs was growing 30 percent, up from just 3 percent in 2014 (Staton)
Even among those that don't report significant clinical side effects, the financial burden of these drugs, as well as the injectable nature of the most popular versions (which much be administered via subcutaneous injection), are major deterrents for many patients
Kumar V, Khan AA, Tripathi A, Dixit PK, Bajaj U
US$ 29.53
US$ 29.38
US$ 24.96
US$ 29.97
US$ 25.74
